Navigation Links
RPGSi Selects M2SYS Fingerprint Biometrics Software for Revolutionary Patient Identification System
Date:1/13/2009

Leading Healthcare Solutions Provider Integrates Award-Winning Fingerprint Recognition Solution

ATLANTA, Jan. 13 /PRNewswire/ -- M2SYS Technology, an award-winning fingerprint biometrics research and development firm, announced today that RPGSi Business Solutions, a provider of effective and high quality technology and information systems to Latin America, has integrated M2SYS' Bio-Plugin(TM) Appserver fingerprint software into its HealthGest(TM) healthcare software. RPGSi will be distributing the fingerprint recognition solution with M2SYS' M2-S(TM) optical fingerprint reader.

HealthGest(TM), a module of the TopSaude(TM) strategic e-health information system, supports the main activities of clinics in collaborative working environments and maintains the actions of public and private ambulatory health care units. With the integration of Bio-Plugin(TM) Appserver, an enterprise-ready, client/server fingerprint biometrics system that eliminates the development effort associated with a low-level fingerprint SDK, the identification of patients in the hospital will be more safe and efficient.

Luis Fernandes, Partner of RPGSi commented, "Most developing nations do not have a reliable method of identifying patients that are in need of healthcare services. Biometrics solves this problem and reduces the health risks to patients from misidentification. Furthermore, the M2SYS Bio-Plugin(TM) fingerprint software has helped us to address the challenge of creating a single Electronic Health Record to identify patients. By the end of this year, we expect to enroll and validate 30% of patients within our first community of 100,000 people," he stated.

"Proper identification of patients in developing countries is critical to provide quality healthcare. The addition of our Bio-Plugin(TM) software solution will give RPGSi a strong competitive advantage while providing their customers with the sophisticated identity protection that they require," stated Michael Trader, President of M2SYS Technology. "With this partnership, M2SYS has strengthened its position as a leading provider of fingerprint technology to the healthcare industry," he added.

About M2SYS

M2SYS Technology, www.m2sys.com, is a recognized industry leader in fingerprint identity management technology, delivering a wide range of customized, fully functional, turn-key fingerprint software solutions for businesses and consumers. M2SYS Technology was awarded the prestigious Frost and Sullivan Biometric Technology Innovation of the Year award in 2007.

About RPGSi

RPGSi, www.rpgsi.com, was founded in 2001 with a vision to provide its customers with efficient solutions with patterns of high quality, as well as areas of technologies and systems for information. RPGSi's main concern has always been its customers.

This release was issued on behalf of the above organization by Send2Press(R), a unit of Neotrope(R). http://www.Send2Press.com


'/>"/>
SOURCE M2SYS Technology
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Womans Hospital Selects rL Solutions for Improved Adverse Event and Patient Safety Reporting
2. Michigan CardioVascular Institute Selects Sage Intergy EHR to Streamline Clinical, Workflow and Reporting Efficiencies
3. Business First Selects DRE Medical Equipment as a Company of the Year
4. BNC Technologies Selects Raima Database Manager Embedded
5. CMS Selects Palmetto GBA to Administer Medicare Program in Four States
6. Medical Economics Selects Jim Hohman to the 150 Best Financial Advisors for Doctors in America List
7. Physician Associates, LLC Selects Allscripts Electronic Health Record to Connect and Automate 80 Physicians
8. Matrixx Initiatives Selects GolinHarris as Agency of Record for Zicam Brand
9. Excela Health Selects Allscripts Electronic Health Record for Physicians
10. Medical Specialists of the Palm Beaches Selects Allscripts Electronic Health Record to Connect and Automate 85 Physicians
11. Minnesota Power Selects InSteps eDNA Historian Software for Enterprise Operational and Asset Health Related Data Management
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/25/2017)... ... September 25, 2017 , ... Order Custom ... new website. No need to be concerned about garment selection, expensive graphic ... where all orders are printed and shipped within 5-10 days. And every ...
(Date:9/25/2017)... ... September 25, 2017 , ... Catalent Pharma Solutions, ... biologics and consumer health products, today announced that two of its leading biologics ... at two upcoming conferences. , At the BEBPA 10th Annual Bioassay Conference, to ...
(Date:9/25/2017)... ... 25, 2017 , ... NCPDP Foundation , a 501(c)(3) ... awarded a $40,000 grant to Johns Hopkins Medicine to address patient safety risk ... to electronically cancel a prescription already submitted to a pharmacy. Studies indicate that ...
(Date:9/25/2017)... ... September 25, 2017 , ... ... and efficiency. The principle of First-Defect-Stop for laboratory weighing is designed ... have the chance to have negative consequences on downstream processes. , If a ...
(Date:9/25/2017)... ... September 25, 2017 , ... ... science and technology-enabled services supporting clinical research, today announces that 30 of ... aspects of the drug development lifecycle at upcoming industry conferences and webinars. ...
Breaking Medicine News(10 mins):
(Date:9/19/2017)... medical device company developing a non-invasive, robotically assisted, platform therapy that uses pulsed sound energy ... ... Jim Bertolina, PhD ... Tom Tefft ... executive Josh Stopek , PhD, who has led R&D and business development teams at ...
(Date:9/12/2017)... PARIS and NEW YORK , Sept. 12, ... ethical performance ratings for global supply chains, has published the first annual ... the CSR performance of more than 20,400 companies evaluated by EcoVadis, based ... years 2015 and 2016. ... EcoVadis Global CSR Risk & Performance Index ...
(Date:9/9/2017)... -- Eli Lilly and Company (NYSE: LLY ) ... lasmiditan, an investigational, oral, first-in-class molecule for the acute ... to placebo in the Phase 3 SPARTAN study. Detailed ... of the International Headache Society (IHC) in ... demonstrate lasmiditan,s potential to reduce pain and provide freedom ...
Breaking Medicine Technology: